Pleiotropic cell-based mechanism

A pleiotropic cell-based mechanism refers to a therapeutic approach where the drug or intervention exerts its effects through multiple, often interconnected, biological pathways rather than a single discrete molecular target. This phenomenon is frequently observed in phenotypic drug discovery, where compounds are selected based on their ability to alter a cellular or physiological outcome without prior knowledge of the specific binding site (Moffat et al., 2017, Nature Reviews Drug Discovery). Such mechanisms are also characteristic of cell-based therapies, such as mesenchymal stem cells, which secrete a variety of paracrine factors to modulate inflammation and promote tissue repair across various organ systems (Galipeau & Sensébé, 2018, Cell Stem Cell). Because these interventions influence a broad array of cellular functions—including signal transduction, gene expression, and metabolic flux—they can offer robust efficacy in complex diseases like cancer or autoimmunity. However, the lack of a specific molecular target poses significant challenges for traditional pharmacological modeling, safety assessment, and the identification of precise biomarkers for patient stratification (Terstappen et al., 2007, Nature Reviews Drug Discovery).

Other names

Non-discrete molecular targetPhenotypic drug mechanismMulti-target cellular effectSystemic cellular responsePolypharmacological mechanism

Simultaneous modulation of multiple intracellular signaling cascades and physiological pathways through complex cellular interactions rather than binding to a single, discrete protein target.